Paper42569744
Evaluation of salivary vimentin in oral erosive lichen planus, oral leukoplakia, oral squamous cell carcinoma and healthy subjects using ELISA.
Arjun O and 2 others. J Oral Maxillofac Pathol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of salivary vimentin in oral erosive lichen planus, oral leukoplakia, oral squamous cell carcinoma and healthy subjects using ELISA. Papers, record 42569744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42569744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of salivary vimentin in oral erosive lichen planus, oral leukoplakia, oral squamous cell carcinoma and healthy subjects using ELISA.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27162585 | Transition of Immunohistochemical Expression of E-Cadherin and Vimentin from Premalignant to Malignant Lesions of Oral Cavity and Oropharynx. | Oman Med J | 2016 | https://conductscience.org/library/papers/27162585 | PubMed |
| 2 | 35207438 | Biomarker Potential of Vimentin in Oral Cancers. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35207438 | PubMed |
| 3 | 280847 | Definition of leukoplakia and related lesions: an aid to studies on oral precancer. | Oral Surg Oral Med Oral Pathol | 1978 | https://conductscience.org/library/papers/280847 | PubMed |
| 4 | 36213468 | Role of Vimentin and E-cadherin Expression in Premalignant and Malignant Lesions of Oral Cavity. | Indian J Otolaryngol Head Neck Surg | 2022 | https://conductscience.org/library/papers/36213468 | PubMed |
| 5 | 26045832 | Expression of E-cadherin and vimentin in oral squamous cell carcinoma. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26045832 | PubMed |
| 6 | 35968190 | Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma - An immunohistochemical study. | J Oral Maxillofac Pathol | 2022 | https://conductscience.org/library/papers/35968190 | PubMed |
| 7 | 30189187 | Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation. | Exp Mol Pathol | 2018 | https://conductscience.org/library/papers/30189187 | PubMed |
| 8 | 35498535 | 2D-DIGE-Based Proteomic Profiling with Validations Identifies Vimentin as a Secretory Biomarker Useful for Early Detection and Poor Prognosis in Oral Cancers. | J Oncol | 2022 | https://conductscience.org/library/papers/35498535 | PubMed |
| 9 | 8056441 | Risk assessment of tobacco, alcohol and diet in oral cancer--a case-control study. | Int J Cancer | 1994 | https://conductscience.org/library/papers/8056441 | PubMed |
| 10 | 10922335 | Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India. | Int J Epidemiol | 2000 | https://conductscience.org/library/papers/10922335 | PubMed |
| 11 | 37445290 | Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia. | J Clin Med | 2023 | https://conductscience.org/library/papers/37445290 | PubMed |
| 12 | 22991586 | Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. | J Dent Res Dent Clin Dent Prospects | 2010 | https://conductscience.org/library/papers/22991586 | PubMed |
| 13 | 23244115 | Risk factors for oral cancer in northeast Thailand. | Asian Pac J Cancer Prev | 2012 | https://conductscience.org/library/papers/23244115 | PubMed |
| 14 | 39198076 | Malignant transformation rate of erosive oral lichen planus: a retrospective study. | Br J Oral Maxillofac Surg | 2024 | https://conductscience.org/library/papers/39198076 | PubMed |
| 15 | 21637948 | Vimentin in cancer and its potential as a molecular target for cancer therapy. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21637948 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42569744
GET https://conductscience.org/api/papers/v1/42569744/authors